111 related articles for article (PubMed ID: 6279339)
41. Fibroblast alpha-galactosidase A activity for identification of Fabry's disease heterozygotes.
Fensom AH; Benson PF; Grant AR; Jacobs L
J Inherit Metab Dis; 1980; 2(1):9-12. PubMed ID: 6273649
[TBL] [Abstract][Full Text] [Related]
42. Screening patients with hypertrophic cardiomyopathy for Fabry disease using a filter-paper test: the FOCUS study.
Hagège AA; Caudron E; Damy T; Roudaut R; Millaire A; Etchecopar-Chevreuil C; Tran TC; Jabbour F; Boucly C; Prognon P; Charron P; Germain DP;
Heart; 2011 Jan; 97(2):131-6. PubMed ID: 21062768
[TBL] [Abstract][Full Text] [Related]
43. Absence of α-galactosidase cross-correction in Fabry heterozygote cultured skin fibroblasts.
Fuller M; Mellett N; Hein LK; Brooks DA; Meikle PJ
Mol Genet Metab; 2015 Feb; 114(2):268-73. PubMed ID: 25468650
[TBL] [Abstract][Full Text] [Related]
44. [Alpha-galactosidase A deficiency--Fabry's disease].
Tsuji S
Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):745-8. PubMed ID: 2855953
[No Abstract] [Full Text] [Related]
45. Synthesis and processing of alpha-galactosidase A in human fibroblasts. Evidence for different mutations in Fabry disease.
Lemansky P; Bishop DF; Desnick RJ; Hasilik A; von Figura K
J Biol Chem; 1987 Feb; 262(5):2062-5. PubMed ID: 3029062
[TBL] [Abstract][Full Text] [Related]
46. Detection of Fabry's disease heterozygotes by enzyme analysis in single fibroblasts after cell sorting.
Jongkind JF; Verkerk A; Niermeijer MF
Clin Genet; 1983 Apr; 23(4):261-6. PubMed ID: 6303650
[TBL] [Abstract][Full Text] [Related]
47. Beta-galactosidase activity in fibroblasts and tissues from sheep with a lysosomal storage disease.
Ahern-Rindell AJ; Murnane RD; Prieur DJ
Biochem Genet; 1988 Dec; 26(11-12):733-46. PubMed ID: 3149466
[TBL] [Abstract][Full Text] [Related]
48. Deficiency of lysosomal hydrolases in apparently healthy individuals.
Zlotogora J; Bach G
Am J Med Genet; 1983 Jan; 14(1):73-80. PubMed ID: 6131608
[TBL] [Abstract][Full Text] [Related]
49. [Molecular forms of human leukocytic alpha-galactosidase and N-acetyl-alpha-galactosaminidase].
Salvayre R; Maret A; Nègre A; Douste-Blazy L
C R Seances Acad Sci D; 1979 Mar; 288(12):995-8. PubMed ID: 223774
[TBL] [Abstract][Full Text] [Related]
50. Enzyme replacement in Fabry disease: treatment of cultured skin fibroblasts with a purified alpha-galactosidase from ficin.
Dawson G; Matalon R; Li YT
Birth Defects Orig Artic Ser; 1973 Mar; 9(2):97-101. PubMed ID: 4215480
[No Abstract] [Full Text] [Related]
51. Lysosomal alpha-galactosidase in endothelial cell cultures established from a Fabry hemizygous and normal umbilical veins.
Hasholt L; Sørensen SA
Hum Genet; 1986 Jan; 72(1):72-6. PubMed ID: 3002954
[TBL] [Abstract][Full Text] [Related]
52. Use of lissamine rhodamine ceramide trihexoside as a functional assay for alpha-galactosidase A in intact cells.
Kaneski CR; Schiffmann R; Brady RO; Murray GJ
J Lipid Res; 2010 Sep; 51(9):2808-17. PubMed ID: 20526001
[TBL] [Abstract][Full Text] [Related]
53. Properties of the residual alpha-galactosidase activity in the tissues of a Fabry hemizygote.
Rietra PJ; Van den Bergh FA; Tager JM
Clin Chim Acta; 1975 Aug; 62(3):401-13. PubMed ID: 809216
[TBL] [Abstract][Full Text] [Related]
54. Detection of Fabry's disease carriers by enzyme assay of hair roots.
Hatton CE; Cooper A; Sardharwalla IB
J Inherit Metab Dis; 1989; 12 Suppl 2():369-71. PubMed ID: 2556612
[No Abstract] [Full Text] [Related]
55. Residual activity of alpha-galactosidase A in Fabry's disease.
Romeo G; D'Urso M; Pisacane A; Blum E; De Falco A; Ruffilli A
Biochem Genet; 1975 Oct; 13(9-10):615-28. PubMed ID: 812485
[TBL] [Abstract][Full Text] [Related]
56. Fabry disease: diagnosis by alpha-galactosidase activities in tears.
Johnson DL; Del Monte MA; Cotlier E; Desnick RJ
Clin Chim Acta; 1975 Aug; 63(1):81-90. PubMed ID: 241513
[TBL] [Abstract][Full Text] [Related]
57. A microtechnique for quantitative measurements of acid hydrolases in fibroblasts. Its application in diagnosis of Fabry disease and enzyme replacement studies.
Hasholt L; Sørensen SA
Clin Chim Acta; 1984 Sep; 142(2):257-61. PubMed ID: 6094040
[No Abstract] [Full Text] [Related]
58. Comparing the alpha-galactosidase A biochemical properties from healthy individuals and Fabry disease patients.
Daitx VV; Mezzalira J; Moraes Vda C; Breier AC; Cé J; Coelho JC
Clin Chim Acta; 2015 May; 445():60-4. PubMed ID: 25804996
[TBL] [Abstract][Full Text] [Related]
59. Evidence for preferential X-chromosome inactivation in a family with Fabry disease.
Ropers HH; Wienker TF; Grimm T; Schroetter K; Bender K
Am J Hum Genet; 1977 Jul; 29(4):361-70. PubMed ID: 406783
[TBL] [Abstract][Full Text] [Related]
60. Relationship between biochemical and clinical features in an English Anderson-Fabry family.
Hamers MN; Wise D; Ejiofor A; Strijland A; Robinson D; Tager JM
Acta Med Scand; 1979; 206(1-2):5-10. PubMed ID: 225929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
